Join NFCR and Dr. Sujuan Ba in Discussion about All Things Cancer
Each episode of All Things Cancer will spotlight the most pressing topics in oncology, from cutting-edge treatments and emerging research to personal stories of resilience and hope. More than just a podcast, it’s a platform for raising awareness, advancing cancer education, and fostering a global community of support and collaboration.
Cancer impacts everyone—whether you’re a patient, caregiver, advocate, or researcher — This podcast delivers invaluable insights from those on the frontlines of the fight against it.
Subscribe now to stay up to date on the latest episodes and join the conversation shaping the future of cancer research.
LISTEN NOW:
Latest Episodes of All Things Cancer
Episode #17:
FEATURING: Kathy Giusti, founder of the Multiple Myeloma Research Foundation
In conversation with Dr. Sujuan Ba. Kathy talks through her diagnosis at 37, how that urgency drove her to build the MMRF, and the collaborative funding model she created that brought together pharma, academia, and the FDA to accelerate drug development — without claiming any IP.
Listen Now On: Spotify | Apple Podcasts | YouTube | Amazon Music

Episode #16:
FEATURING: Dr. Michele Carbone on How Research Saves Communities
Dr. Carbone was invited to visit villages where nearly half the population was dying from mesothelioma, a rare cancer of the lung lining. What he uncovered was far more complex than environmental exposure alone.
Listen Now On: Spotify | Apple | Youtube | Amazon Music

Episode #15:
We’re Drowning in Cancer Data — And Still Missing Cures with Dr. Anna Barker
In the latest episode of All Things Cancer, Dr. Sujuan Ba sits down with Ann Barker, one of the most influential architects of modern cancer research, for a wide-ranging conversation about where the field is headed and what’s standing in the way of real progress. At the heart of the discussion is a simple but uncomfortable truth: cancer research has more data than ever before, but we are not fully equipped to use it.










